| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Unicycive Therapeutics, Inc. | Director | Common Stock | 1,789,915 | $7,607,138 | $4.25 | 25 Aug 2025 | By Vivo Opportunity Fund Holdings L.P. |
| Unicycive Therapeutics, Inc. | Director | Series A-2 Prime Preferred Stock | 0 | $0 | $1000.00 | 25 Aug 2025 | By Vivo Opportunity Fund Holdings L.P. |
| GERON CORP | Director | Stock Option (right to buy) | 180,000 | 21 May 2025 | Direct | ||
| Unicycive Therapeutics, Inc. | Director | Stock Options | 39,200 | 28 Jul 2025 | Direct | ||
| Sierra Oncology, Inc. | Director | Common Stock | 0 | $55.00 | 01 Jul 2022 | By: Vivo Opportunity Fund Holdings, L.P. | |
| Sierra Oncology, Inc. | Director | Series A Warrant | 0 | 01 Jul 2022 | By: Vivo Opportunity Fund Holdings, L.P. | ||
| Sierra Oncology, Inc. | Director | Series B Warrant (Right to Purchase) | 0 | 26 Jan 2022 | By Vivo Opportunity Fund, L.P. | ||
| Sierra Oncology, Inc. | Director | Stock Option (right to buy) | 0 | 01 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| UNCY | Unicycive Therapeutics, Inc. | 25 Aug 2025 | 2 | -$3,199,210 | 4 | Director | 26 Aug 2025, 17:06 |
| UNCY | Unicycive Therapeutics, Inc. | 28 Jul 2025 | 1 | $0 | 4 | Director | 30 Jul 2025, 16:30 |
| GERN | GERON CORP | 21 May 2025 | 1 | $0 | 4 | Director | 22 May 2025, 17:07 |
| UNCY | Unicycive Therapeutics, Inc. | 18 Feb 2025 | 2 | -$686,000 | 4 | Director | 19 Feb 2025, 11:55 |
| UNCY | Unicycive Therapeutics, Inc. | 09 Oct 2024 | 2 | -$2,695,000 | 4 | Director | 10 Oct 2024, 17:15 |
| GERN | GERON CORP | 09 May 2024 | 1 | $0 | 4 | Director | 10 May 2024, 16:05 |
| GERN | GERON CORP | 29 Dec 2023 | 1 | $0 | 4 | Director | 03 Jan 2024, 19:02 |
| GERN | GERON CORP | 26 Nov 2023 | 1 | $0 | 4 | Director | 28 Nov 2023, 16:10 |
| GERN | GERON CORP | 26 Nov 2023 | 0 | $0 | 3 | Director | 28 Nov 2023, 16:08 |
| UNCY | Unicycive Therapeutics, Inc. | 05 Sep 2023 | 1 | $0 | 4 | Director | 07 Sep 2023, 17:30 |
| UNCY | Unicycive Therapeutics, Inc. | 11 Jul 2023 | 6 | -$8,077,000 | 4 | Director | 13 Jul 2023, 20:42 |
| UNCY | Unicycive Therapeutics, Inc. | 08 Mar 2023 | 1 | +$8,077,000 | 4 | Director | 09 Mar 2023, 20:39 |
| UNCY | Unicycive Therapeutics, Inc. | 08 Mar 2023 | 0 | $0 | 3 | Director | 08 Mar 2023, 15:11 |
| /report/000120919122040279-aggarwal-gaurav-2022-07-01 | Sierra Oncology, Inc. | 01 Jul 2022 | 5 | -$150,471,915 | 4 | Director | 01 Jul 2022, 16:45 |
| /report/000120919122005748-aggarwal-gaurav-2022-01-31 | Sierra Oncology, Inc. | 31 Jan 2022 | 1 | +$21,600,000 | 4 | Director, 10%+ Owner | 31 Jan 2022, 17:47 |
| /report/000120919122005503-aggarwal-gaurav-2022-01-26 | Sierra Oncology, Inc. | 26 Jan 2022 | 2 | -$12,871,412 | 4 | Director, 10%+ Owner | 28 Jan 2022, 18:53 |
| /report/000120919121039089-aggarwal-gaurav-2021-06-08 | Sierra Oncology, Inc. | 08 Jun 2021 | 1 | $0 | 4 | Director, 10%+ Owner | 09 Jun 2021, 10:29 |